Rapport Therapeutics (RAPP) Amortizatization of Intangibles (2024 - 2026)
Rapport Therapeutics' (RAPP) quarterly Amortizatization of Intangibles came in at $364000.0 in Q1 2026, down 16.51% year-on-year from $436000.0 in Q1 2025, and down 66.04% on a QoQ basis from $1.1 million in Q4 2025.
Rapport Therapeutics (RAPP) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 3 years of Amortizatization of Intangibles data on file, last reported at $364000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 16.51% year-over-year to $364000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 50.39% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 56.52% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $364000.0, down from $1.1 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for RAPP reached as high as $2.0 million in Q3 2024 and fell as low as -$560000.0 in Q4 2024.
- Historically, Amortizatization of Intangibles has averaged $552333.3 across 3 years, with a median of $436000.0 in 2025.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 291.43% in 2025 and fell as far as 110.39% in 2025.
- Year by year, Amortizatization of Intangibles stood at -$560000.0 in 2024, then jumped by 291.43% to $1.1 million in 2025, then plunged by 66.04% to $364000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $364000.0 in Q1 2026, $1.1 million in Q4 2025, and -$204000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Rapport Therapeutics | 1.95 Bn | 1.95 Bn | - | 364,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364,000.00 |
| Mar 31, 2026 | 364,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | -204,000.00 |
| Sep 30, 2025 | -204,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Mar 31, 2025 | 436,000.00 |
| Mar 31, 2025 | 436,000.00 |
| Dec 31, 2024 | -560,000.00 |
| Dec 31, 2024 | -560,000.00 |
| Sep 30, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 829,000.00 |
| Jun 30, 2024 | 829,000.00 |
| Mar 31, 2024 | 978,000.00 |
| Mar 31, 2024 | 978,000.00 |